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Activator protein 1 (AP-1) proteins play key roles in the regulation of cell proliferation and differentiation. In this
study we investigated the expression of Fos and Jun proteins in different models of terminal differentiation of
human keratinocytes and in skin from psoriasis patients. All Jun and Fos proteins, with the exception of FosB, were
efﬁciently expressed in keratinocytes in monolayer cultures. In contrast, in normal epidermis as well as in organo-
typic epidermal cultures, the expression pattern of AP-1 proteins was dependent on the differentiation stage. Fos
proteins were readily detected in nuclei of keratinocytes of basal and suprabasal layers. JunB and JunD were
expressed in all layers of normal epidermis. Interestingly, expression of c-Jun started suprabasally, then disap-
peared and became detectable again in distinct cells of the outermost granular layer directly at the transition zone
to the stratum corneum. In psoriatic epidermis, c-Jun expression was prominent in both hyperproliferating basal
and suprabasal keratinocytes, whereas c-Fos expression was unchanged. These data indicate that AP-1 proteins
are expressed in a highly specific manner during terminal differentiation of keratinocytes and that the enhanced
expression of c-Jun in basal and suprabasal keratinocytes might contribute to the pathogenesis of psoriasis.
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Terminal differentiation of epidermal keratinocytes begins
when cells migrate out of the basal epidermal layer, stop to
proliferate and move outwards to the spinous and granular
layers. Keratinocytes thereby undergo defined changes fi-
nally giving rise to the mature horny layer of the epidermis
composed of tightly connected corneocytes devoid of nu-
clei that function to protect the body from dehydration and
injury (Fuchs and Byrne, 1994).
The Activator protein 1 (AP-1) transcription factor con-
sists of homo- or heterodimers of members of the Fos (c-
Fos, FosB, Fra-1, and Fra-2) and Jun (c-Jun, JunB, and
JunD) proteins (Shaulian and Karin, 2001). Loss- and gain-
of-function experiments in mice have demonstrated the
central role of AP-1 in many biological processes including
cell proliferation, differentiation, oncogenic transformation,
and apoptosis (Jochum et al, 2001). AP-1 proteins play im-
portant roles during terminal differentiation of epidermal
keratinocytes and therefore the epidermis represents a
highly informative and easily accessible in vivo system to
study AP-1 functions. It is well known that AP-1 regulates
many genes encoding critical players of skin homeostasis
(Angel et al, 2001). These include transglutaminase type I
(Liew and Yamanishi, 1992), different cytokeratin gene fam-
ily members, such as K1 (Lu et al, 1994), K5 (Casatorres
et al, 1994), K14, and K17 (Ma et al, 1997) as well as struc-
tural epidermal proteins like involucrin (Welter et al, 1995),
loricrin (DiSepio et al, 1995), and profilaggrin (Jang et al,
1996). Although in mice inactivation of some AP-1 proteins
did not reveal an overt skin phenotype (Angel et al, 2001), it
is difficult to speculate about AP-1 functions in mouse skin
as loss of JunB and Fra-1 results in embryonic lethality (Eferl
and Wagner, 2003). Interestingly, the conditional inactivation
of c-Jun in the mouse epidermis has demonstrated that c-
Jun plays an essential role in regulating eyelid closure, ker-
atinocyte proliferation, and skin tumor development through
anti-epidermal growth factor receptor signaling (Li et al,
2003; Zenz et al, 2003). Expression of individual AP-1
proteins has also been critically implicated in cytokine-
mediated mesenchymal–epithelial interactions in the skin
(Szabowski et al, 2000). Disturbances in tissue homeostasis
and an aberrant, altered expression of cytokines are likely to
be implicated in human pathological diseases such as pso-
riasis. Psoriasis is a chronic and inflammatory skin disease,
which affects around 3% of the population and is charac-
terized by epidermal abnormalities including keratinocyte
hyperproliferation and altered differentiation leading to
parakeratosis and desquamation (Stern, 1997). In one study
decreased transcription of c-fos and c-jun has been de-
scribed in psoriasis (Basset-Seguin et al, 1991). In contrast,
targeted v-fos expression to mouse keratinocytes efficiently
induced epidermal hyperplasia (Greenhalgh et al, 1993) in-
dicating that the functions of AP-1 in hyperproliferative skin
disorders are still not well understood.
Individual AP-1 proteins are differentially expressed in
epidermal layers, although findings on AP-1 expression in
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the epidermis from different investigators are somehow
discordant. In normal human skin, expression of c-Fos and
c-Jun has been reported to be predominantly confined to
basal and lower spinous cells (Basset-Seguin et al, 1990),
whereas in another study c-Fos has been localized to all
epidermal layers and c-Jun to granular layers of both au-
thentic and reconstructed skin (Briata et al, 1993). In an-
other study, analysis of all AP-1 proteins localized FosB and
Fra-2 in lower, c-Jun and c-Fos in upper, Fra-1 in supra-
basal and JunB as well as JunD in all layers of human neo-
natal epidermis (Welter and Eckert, 1995). We assumed that
unspecific antibodies against AP-1 proteins are responsible
for some of the contradicting results on AP-1 expression in
different models of epidermal differentiation. Using in vitro
translated AP-1 proteins and cells deficient in different AP-1
proteins, we first examined the reactivity of different anti-
bodies with individual AP-1 proteins. These antibodies were
subsequently used to analyze AP-1 expression in different
models of terminal differentiation of human keratinocytes
such as monolayer cultures, in vitro reconstructed epidermis
as well as normal and psoriatic epidermis. We present novel
findings on the specific expression of AP-1 proteins during
terminal differentiation of human keratinocytes and also
demonstrate high expression of c-Jun in psoriatic epidermis.
Results and Discussion
Assessment of the speciﬁcity of anti-AP-1 antibod-
ies Previous reports on AP-1 expression in human epider-
mis showed that primary antibodies developed in rabbits
produced a high background staining (Welter and Eckert,
1995). Therefore, we investigated the specificity of commer-
cially available antibodies against AP-1 proteins (Table S1).
To test antibody cross-reactivity between different sub-
units, in vitro translated AP-1 proteins were analyzed by
western blotting. Among the Fos proteins, the rabbit anti-
Fra-1 antibody cross-reacted with c-Fos, whereas the other
anti-Fos antibodies were detected only the specific sub-
units (Fig S1A). Similarly, among Jun proteins rabbit anti-
JunD cross-reacted with c-Jun, whereas both mouse
monoclonal antibodies anti-c-Jun and JunB detected only
the corresponding Jun proteins (Fig S1B). To evaluate
whether the respective antibodies also detect the different
endogenous AP-1 proteins, serum-starved quiescent hu-
man dermal fibroblasts (HDF) were stimulated 3 h with se-
rum and AP-1 reactivity was analyzed by immunostaining.
Whereas in resting fibroblasts only Fra-2 and JunD were
detected, all Fos and all Jun proteins were induced and
accumulated in the nucleus upon serum stimulation (Fig
S1C,D). No nuclear staining and a low cytoplasmic back-
ground staining were observed when serum-stimulated
fibroblasts were stained with corresponding isotypes or
normal rabbit IgG (Fig S1C,D). Thus, the antibodies used in
these experiments detect all human AP-1 proteins by
immunostaining and are, with the exception of Fra-1 and
JunD AP-1 subunit, specific.
Fos and Jun proteins are expressed in monolayer cul-
tures of human epidermal keratinocytes Since keratin-
ocytes in monolayer cultures exhibit a differentiated
phenotype after prolonged confluence (Eckert et al, 1997;
Chaturvedi et al, 1999), we studied differentiation-associat-
ed AP-1 expression at different time points by immuno-
staining and Western blot analysis. c-Fos localized to the
nucleus of pre-confluent, as well as in 1 and 2 d post-con-
fluent cells, showed a weak cytoplasmic localization at day
4 and virtually disappeared at day 6 after confluence had
been reached (Fig 1A). Using western blot analysis, c-Fos
was detected in nuclear extracts of pre-confluent as well as
1 and 2 d post-confluent normal human epidermal keratin-
ocytes (NHEK) (Fig 1B). The disappearance of c-Fos in later
differentiation stages suggests that it is dispensable for the
expression of terminal differentiation-associated proteins
and the maintenance of differentiation. FosB, which has
been shown previously to be unable to bind to the promoter
of several epidermal genes, could not be detected by
immunostaining at any time point and western blot analysis
only detected a very weak signal in proliferating NHEK
(Fig 1A,B). This is in agreement with earlier findings dem-
onstrating only low FosB RNA levels presenting NHEK
(Gandarillas and Watt, 1995; Rossi et al, 1998). Although
only weakly expressed in pre-confluent cultures, both Fra
proteins were induced in 1 or 2 d post-confluent cells and
were found in nuclear location also at later stages of dif-
ferentiation (Fig 1A). Both Fra proteins were also detectable
in nuclear extracts of post-confluent keratinocytes (Fig 1B).
In contrast to Fos proteins, all Jun proteins were detected in
pre-confluent cells as well as at all time points after con-
fluence had been reached (Fig 1A). Western blot analysis
confirmed that Jun proteins were present at all time points
in nuclear extracts of NHEK with higher expression levels in
post-confluent than pre-confluent cells (Fig 1B). Together
these data demonstrate that whereas Jun proteins are con-
tinuously expressed at all stages of keratinocyte differen-
tiation, Fos proteins show a differential expression pattern in
monolayer cultures. Therefore we assume that in late stages
of keratinocyte differentiation, when c-Fos is absent, Fra-1
and/or Fra-2 may replace it as a partner for Jun.
AP-1 proteins are expressed in a differentiation-stage-
dependent manner during terminal differentiation of
skin equivalents (SE) Keratinocytes co-cultured with fib-
roblasts from SE mimic the natural architecture of the ep-
idermis in a simplified form and represent a powerful model
to study keratinocyte differentiation (Fusenig, 1994). The
expression of different AP-1 components was next analy-
zed during terminal differentiation of keratinocytes in such
organotypic cultures.
SE were followed up to 8 d after initiating differentiation
by lifting the epidermis to the air–liquid interface (Fig 2A).
Under these conditions differentiation markers like filaggrin
or caspase-14 were expressed as previously described
(Eckhart et al, 2000; Rendl et al, 2002). Although in an earlier
study c-Fos was detected in organotypic cultures only after
prolonged culture (Basset-Seguin et al, 1994), in our study
c-Fos was present in the cytoplasm of basal cells already at
day 2 after initiating differentiation. Its expression increased
and extended to suprabasal cells as differentiation progres-
sed resulting in nuclear localization from day 4 onwards.
In the uppermost layers of nucleated cells corresponding to
the granular layer of the epidermis, c-Fos expression was
AP-1 EXPRESSION IN NORMAL AND PSORIATIC EPIDERMIS 213124 : 1 JANUARY 2005
detected only in few cells (Fig 2B). As observed in mono-
layer cultures of keratinocytes, we did not detect FosB at
any differentiation stage (Fig 2B). Both Fra-1 and Fra-2
showed faint cytoplasmic staining in SE up to day 6 when
expression was also found in the nucleus (Fig 2B). These
data demonstrate that Fra proteins are available as partners
for the AP-1 complex in late stage of keratinocyte differen-
tiation confirming their potential roles in regulating keratin-
ocyte gene expression (Welter et al, 1995; Medvedev et al,
1999; Hanley et al, 2001). The time course of their trans-
location to the nucleus indicates that Fra proteins may play
a role in the homeostasis of already differentiated epidermis
rather than in the actual differentiation process.
Jun proteins were expressed from days 2 to 8 of SE
differentiation. At all time points analyzed c-Jun expression
showed a unique expression pattern. Staining was restrict-
ed to the basal and first layer of suprabasal cells as well as
to cells of the granular layer, but absent in most cells in
between. Moreover, the expression in the granular layer was
more strongly than in the basal layers (Fig 2C). JunB was
expressed at all time points of investigation and localized to
the nucleus. The distribution, however, developed from a
uniform to a scattered pattern in all epidermal layers from
days 6 to 8 (Fig 2C). JunD predominantly accumulated in
the cytoplasm at day 2, but was found in the nuclei of basal
cells at day 4. The distinct distribution of JunD first became
clearly detectable in suprabasal cells at day 8 (Fig 2C).
Thus, during terminal differentiation of SE cultures, where
the authentic epidermal architecture is reflected in a more
genuine manner than in keratinocytes in monolayer cultures,
Figure 1
Activator protein 1 (AP-1) proteins are expressed in monolayer culture of epidermal keratinocytes. Differentiation of normal human epidermal
keratinocytes (NHEK) was induced by confluence. Cells were either fixed on cover slips or lysed at the indicated time points (in days). (A)
Immunostaining of Fos and Jun proteins in monolayer culture was performed at the indicated time points. (B) Western blot analysis of Fos and Jun
expression at the indicated time points of NHEK differentiation. Thirty micrograms of nuclear extracts were analyzed on gradient gels. Positive
controls (þ ) were in vitro translated AP-1 proteins, with the exception of FosB where lysates from FosB-transfected 293 cells were used. For
negative controls (), extracts from fibroblasts deficient in corresponding AP-1 subunits were loaded, except for FosB, where extracts from starved
human dermal fibroblasts were used. Ponceau S staining was used to control the loading. Scale bars¼ 50 mm.
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Figure 2
Activator protein 1 proteins are expressed in a stage-dependent manner during in vitro differentiation of skin equivalents (SE). (A) Hem-
atoxylin and eosin staining of in vitro differentiated SE generated by culture at the air–liquid interface at the indicated time points showing stratum
basale (sb), stratum spinosum (ss), stratum granulosum (sg), and stratum corneum (sc). (B) Expression of Fos proteins during in vitro differentiation
of SE was analyzed by immunofluorescence. At the indicated time points, sections were stained with antibodies against Fos proteins. (C) Expression
of Jun proteins during in vitro differentiation of SE. Immunostaining at the indicated time points was performed using Jun antibodies. Black dotted
lines indicate the different epidermal strata of SE and white dotted lines indicate the borders of SE epidermis. Scale bars¼50 mm.
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the different AP-1 proteins showed differentiation-stage-as-
sociated expression (summarized in Fig 5). Although c-Jun
expression in the uppermost layers has already been re-
ported (Briata et al, 1993; Welter and Eckert, 1995), we
show for the first time that c-Jun expression differed at dif-
ferent stages of keratinocyte differentiation, i.e. c-Jun was
prominently expressed in basal cells of SE, not detectable in
upper suprabasal cells and reoccurred in cells of the gran-
ular layer.
AP-1 proteins are differentially expressed in human ep-
idermis We next assessed the expression of AP-1 proteins
in human epidermis. Only marginal background staining
was observed when isotype controls or normal rabbit IgG
were used as primary antibodies (Fig 3A). When using the
specific antibodies, a highly differential expression of AP-1
proteins was found in the human epidermis. c-Fos was ex-
pressed in the nuclei of all epidermal layers with slightly
decreased intensity in the granular keratinocytes (Fig 3B).
Our results are in agreement with two earlier reports on c-
Fos expression (Basset-Seguin et al, 1990; Briata et al,
1993), but in contrast to another report (Welter and Eckert,
1995). These differences might be because of the use of
different antibodies. Like in NHEK and SE, FosB was not
detectable in human epidermis (Fig 3B). Interestingly, Fra-1
was detected predominantly in the nuclei of spinous and to
a lower extent in basal layers, whereas Fra-2 expression
was mainly confined to the nuclei of basal and spinous cells
(Fig 3B). These findings are in agreement with published
observations (Welter and Eckert, 1995) with the notable
difference that we found Fra proteins predominantly in the
nuclei. These data indicate that Fra proteins are available as
Figure3
Activator protein 1 proteins are differentially expressed in hu-
man epidermis. (A) Hematoxylin and eosin staining of adult hu-
man skin showing stratum basale (sb), stratum spinosum (ss),
stratum granulosum (sg), and stratum corneum (sc). Different
immunoglobulin isotypes were used to evaluate the background
staining of antibodies in human skin. (B) Immunolocalization of
Fos proteins in human epidermis. Sections were stained with
antibodies directed against cFos, FosB, Fra-1, and Fra-2. (C)
Immunolocalization of Jun proteins in human epidermis. Immuno-
staining was performed using antibodies against c-Jun, JunB, and
JunD. DNA was counterstained with Hoechst dye. Black dotted
lines indicate the different epidermal strata of normal human ep-
idermis and white dotted lines indicate the borders of the epider-
mis. Scale bars¼50 mm.
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partners for the AP-1 complex confirming their potential
roles in regulating epidermal gene expression in vivo. This is
further supported by studies on the role of these family
proteins in the activation of promoters of several differen-
tiation-associated keratinocyte genes (Welter et al, 1995;
Medvedev et al, 1999; Hanley et al, 2001).
Among Jun proteins, c-Jun showed an interesting ex-
pression pattern. Although virtually absent from basal cells,
c-Jun-stained cells of the first suprabasal and lower spin-
ous layers was not detected in cells of the upper spinous
layer, but intense staining reappeared in cells of the granular
layer (Fig 3C). By contrast anti-JunB and JunD antibodies
stained all epidermal layers. The intensity of the JunB signal
increased in the upper spinous layers and in the granular
layer, whereas JunD was expressed at equal levels in all
epidermal layers (Fig 3C). Although c-Jun expression in
cells of the granular layer has been reported previously
(Briata et al, 1993; Welter and Eckert, 1995), we show for the
first time that c-Jun is regularly present in suprabasal and
infrequently also in basal cells. As also depicted and quan-
tified in Fig 4C, c-Jun expression in the outermost nucleated
cells of the granular layer of normal epidermis strongly ex-
ceeded that in the other layers. Together with the findings
that also JunB was stronger expressed in these cells, our
data indicate that Jun proteins might play a central role in
the last steps of keratinocyte terminal differentiation. Fur-
thermore, as described above c-Fos expression was re-
duced in the outermost cells of the granular layer; our data
also suggest that in this location Jun homodimers might
preferentially form. The data on the expression of AP-1
family members in authentic epidermis are summarized in
Fig 5.
Expression of c-Jun is increased in psoriasis Keratin-
ocyte hyperproliferation and altered differentiation are hall-
marks of psoriasis. We assumed an involvement of AP-1 in
these steps and postulated that AP-1 expression could be
altered in psoriasis. Since heterogeneous cytokine expres-
sion and inflammation in psoriatic skin induced a strong
background staining with rabbit polyclonal antibodies
raised against several AP-1 proteins, the analysis of AP-1
expression in psoriasis was limited to c-Fos and c-Jun. In
contrast to the previously reported decrease of c-fos and c-
jun RNA (Basset-Seguin et al, 1991), we found that in
analogy to healthy epidermis (Fig 4B) c-Fos protein was
expressed in all layers of psoriatic epidermis (Fig 4B).
Quantification of the c-Fos signal revealed a comparable
signal intensity of c-Fos in both specimens from healthy and
psoriatic epidermis (Fig 4B) indicating that regulation of c-
Fos expression might not play a major role in the patho-
genesis of psoriasis. In contrast to normal epidermis where
c-Jun was strongly positive in the outermost layer of
granular cells, in psoriatic epidermis expression extended
to several subcorneal layers. In addition c-Jun was
also strongly expressed in basal keratinocytes (Fig 4C). A
semi-quantitative analysis of the c-Jun signal confirmed
that c-Jun expression in nuclei of subcorneal cells exceed-
ed that in the other cell layers in both normal and psoriatic
epidermis (Fig 4C).
To investigate a possible correlation between increased
c-Jun expression and the expression of differentiation-as-
sociated genes in psoriasis, co-localization studies were
performed. In contrast to normal skin, involucrin staining
extended to the first suprabasal layers in psoriasis (Dover
and Watt, 1987). Staining on serial sections, however,
Figure 4
Increased expression of c-
Jun in psoriasis. (A) Hem-
atoxylin and eosin staining of
normal and psoriatic epidermis
showing different epidermal
strata. Note the pronounced
acanthosis and parakeratosis
in psoriasis. Representative im-
munofluoresecence staining of
psoriatic and normal epidermis
using antibodies against c-Fos
(B) and c-Jun (C) is shown.
The intensity of the signal
was measured in all layers
and quantified using Meta-
morph Software. The average
intensity of the signal was nor-
malized for the background
staining and is indicated in ar-
bitrary units obtained from
counts of normal (n¼3) and
psoriatic (n¼5) epidermis for
c-Fos (B) and c-Jun (C). Bas,
basal layer; spin, spinous layer;
gran, granular layer; nhe, nor-
mal human epidermis; nhs,
normal human skin. Black dot-
ted lines indicate the different
epidermal strata of normal and
psoriatic epidermis and white
dotted lines indicate the bor-
ders of normal and psoriatic
epidermis. Scale bars¼ 50 mm.
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revealed no clear association between involucrin and al-
tered c-Jun expression in psoriasis (data not shown). In
contrast to normal skin and in agreement with a previous
study (Bernerd et al, 1992), K5 expression extended to the
suprabasal keratinocytes in psoriasis but also here no as-
sociation with the change in c-Jun expression in psoriasis
was found (data not shown). Thus, altered c-Jun expression
does not coincide with upregulated K5 or involucrin ex-
pression in psoriasis.
Although c-Fos protein expression appears unchanged
in normal and psoriatic epidermis, c-Jun expression is en-
hanced in psoriatic epidermis. In most cases c-Jun is a
positive regulator of cell proliferation (Shaulian and Karin,
2001; Zenz et al, 2003). Since keratinocyte hyperprolifera-
tion is a hallmark of psoriasis, upregulation of c-Jun in basal
keratinocytes might contribute to the pathogenesis of this
disease. The data on c-Jun expression were also corrob-
orated by the results obtained with a mouse monoclonal
antibody against activated forms of c-Jun that revealed that
not only expression but also activation of c-Jun was in-
creased in psoriasis (data not shown). Thus, in contrast to a
decrease in RNA levels of c-jun in psoriasis (Basset-Seguin
et al, 1991), we assume that post-transcriptional mecha-
nisms might account for accumulation of c-Jun protein in
psoriasis. A reason for increased c-Jun expression in pso-
riasis might be the altered cytokine signaling in this disease.
Among the cytokines that are present in hyperproliferative
psoriatic plaques, tumor necrosis factor a (TNFa), which has
both proliferative and inflammatory effects, is strongly en-
hanced in psoriasis (Ettehadi et al, 1994). Blocking the ac-
tion of TNFa represents a powerful approach to treat skin
inflammation including psoriasis (Kirby and Griffiths, 2002).
Interestingly, TNFa can induce proliferation via TRAF2, ME-
KK1, and JNK recruitment resulting in subsequent c-Jun
activation (Aggarwal, 2003). Thus, it is tempting to specu-
late that increased TNFa production in psoriasis might ac-
tivate c-Jun leading to the observed hyperproliferation.
Since c-Fos expression was not altered in psoriasis com-
pared with normal epidermis, c-Fos could be the dimerizat-
ion partner for c-Jun in hyperproliferative layers of psoriatic
epidermis. The availability of c-Fos and c-Jun in basal
psoriatic layers could give rise to Jun/Fos heterodimers,
which as potent gene activators (van Dam and Castellazzi,
2001) might contribute to increased proliferation of psoriatic
basal keratinocytes resulting in acanthosis.
Taken together, our data clarify some of the contradicting
and previously published reports on AP-1 expression in
human epidermis. This study provides a foundation for fu-
ture examinations of AP-1 functions during differentiation of
human keratinocytes and in skin diseases.
Material and Methods
Skin samples Normal skin samples were derived from mammary
(n¼ 2) and abdominal (n¼ 2) reduction surgery. For the studies on
psoriatic skin biopsy specimens from the histopathology files of
the Derpartment of Dermatology, Medical University of Vienna,
obtained after informed consent for diagnostic purposes, were
used. The specimens were derived from lesional skin of eight (five
females, three males) patients with generalized (n¼ 6) and inversa
type (n¼ 2) psoriasis. The age ranged from 24 to 64 y. All exper-
imental procedures were approved by the Regional Committee for
Medical Research Ethics and were conducted in compliance with
the Helsinki guidelines.
Cell cultures NHEK derived from neonatal foreskin were obtained
from Clonetics (San Diego, California). Keratinocytes between
second and fifth passages were cultured in keratinocyte growth
medium (KGM) containing 0.1 ng per mL human recombinant
epidermal growth factor, 5 mg per mL insulin, 0.5 mg per mL hy-
drocortisone, 0.4% bovine pituitary extract and 50 mg per mL
gentamycin. For keratinocyte differentiation studies, 1  105 cells
were seeded on six-well plates and grown either to pre-confluence
(designated as ‘‘pre-confluent’’) or cultured up to 6 d of post-con-
fluence (designated ‘‘d1–d6’’) prior to fixation or lysis. Media were
changed every other day. HDF were obtained by culturing de-
epidermized skin specimens derived from breast reduction sur-
gery. Fibroblasts between fourth and tenth passages were grown in
Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Gaithers-
burg, Maryland) supplemented with 10% fetal calf serum (FCS) and
1000 U penicillin and streptomycin per mL (Gibco) to sub-conflu-
ence. Cells were starved 2 d in DMEM containing 0.25% FCS prior
to restimulation with 20% FCS and staining with AP-1 antibodies.
Organotypic culture In vitro reconstructed SE were generated
as described (Stark et al, 1999) including several modifications.
Figure 5
Fos and Jun expression in human epidermis. Summary of activator protein 1 expression in normal epidermis and skin equivalents (SE) at day 8 of
differentiation. Schematic representation of human epidermis (see also Angel et al, 2001). Distribution of individual Fos and Jun proteins based on
our findings obtained from authentic and reconstructed human epidermis is indicated. The intensity of expression is given from empty to filled
triangles (SE) or circles (normal epidermis).
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Fibroblasts (1  105 per mL) were suspended in 2.5 mL of a so-
lution containing 2.4 mg per mL bovine collagen type I (Vitrogen,
Cohesion Technologies, Palo Alto, California), 1  Hank’s-buffered
saline solution (Gibco), 10% fetal bovine serum adjusted to pH 7.4
with 2 M NaOH. The mixture was poured into 24 mm cell culture
inserts (Becton Dickinson, Schwechat, Austria) that were placed
into six-well trays (Becton Dickinson) and allowed to gellify at 371C
for 2 h. Thereafter, gels were equilibrated in 16 mL pre-warmed
KGM (2 mL inside, 14 mL outside the insert) at 371C for additional
2 h. The medium inside the insert was replaced with 2 mL KGM
containing keratinocytes (6  105 per mL) and allowed to sub-
merge overnight. The day after, the medium was changed with
10 mL serum-free keratinocyte defined medium (SKDM) com-
posed of KGM without bovine pituitary extract and supplemented
with 10 mg per mL transferrin (Clonetics), 0.1% bovine serum al-
bumine (BSA; Sigma, St. Louis, Missouri) and 50 mg per mL L-
ascorbic acid. Cells were kept at the air–liquid interface from that
time point onwards. SKDM was replaced every other day and SE
were cultured to the indicated time points (designated as ‘‘d1–d8’’)
prior to formalin-fixation, hematoxylin and eosin (H&E) staining, or
immunofluorescence.
Controls Positive controls for AP-1 proteins for western blot anal-
ysis were generated using TNT SP6/T7 coupled reticulocyte lysate
system (Promega, Madison, Wisconsin), except for FosB where
lysates from 293 cells transfected with RSV-mouse FosB were
used. For in vitro translation, either T7-driven (pCMV-mouse JunD,
pGEM-T-human JunB (kind gift from Agnieszka Szremska),
pCDNA3-human Fra-2 (kind gift from Dr Koichi Matsuo) and
pCDNA3-human c-Fos) or SP6-driven (pGEM7-human c-Jun and
pGEM7-mouse Fra-1) vectors were added to the TNT rabbit re-
ticulocyte lysate system that was used as recommended by the
manufacturer (Promega). The mixture was incubated 2 h at 301C
and preserved at 801C. Five microliters aliquots were used for gel
electrophoresis. For negative controls, with the exception of FosB
where extracts isolated from fibroblasts starved for 2 d with 0.25%
FCS were used, all extracts were isolated from mouse fibroblasts
deficient in corresponding AP-1 subunits (kindly provided by Uta
Moehle-Steinlein with the exception of Fra-2/ fibroblasts that
were a generous gift from Dr Robert Eferl and JunD/ fibroblasts
that were kindly provided by Dr Arabella Meixner). Positive and
negative controls were separated on SDS-PAGE using 12% mini
gels (Biorad, Hercules, California) and transferred to nitrocellulose
membranes. Western blot analysis was performed as described
below.
Western blot analysis Mouse fibroblasts were lysed in total cell
lysis buffer containing 20 mM Tris, pH 8, 0.135 M NaCl, 10%
glycerol, 1% NP-40, and protease inhibitor cocktail (Sigma). Thirty
micrograms of total protein extracts were separated through an
8%–18% gradient polyacrylamide gel (Amersham Biosciences,
Piscataway, New Jersey) together with nuclear extracts of NHEK.
To prepare nuclear lysates of NHEK, cells were washed twice in
phosphate-buffered saline (PBS) and resuspended in 10 mM
HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM
DTT, and inhibitor cocktail. Upon swelling cells on ice for 15 min,
6.25% NP-40 were added, vortexed, and centrifuged 1 min at
maximum speed. Pellet was then lysed in 20 mM HEPES, pH 7.9,
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and inhibitor
cocktail. Upon vigorous vortexing and centrifugation for 15 min at
maximum speed, the supernatants were collected as nuclear frac-
tions. Thirty micrograms of nuclear protein extracts were elect-
rophoresed and transferred to nitrocellulose membranes. Blots
were blocked in PBS with 5% non-fat dry milk and 0.1% Tween
and incubated with anti-c-Fos, anti-FosB, anti-Fra-1, anti-Fra-2,
anti-c-Jun, anti-JunB, anti-JunD antibodies overnight at 41C (Table
S1). The blots were washed in PBS with 0.1% Tween and incu-
bated with HRP-conjugated sheep anti-mouse (Amersham Biosci-
ences, Rockford, Illinois) or goat anti-rabbit (Pierce) secondary
antibodies. The blots were developed using ECL chemilumines-
cence detection system (Amersham Biosciences).
Immunostaining and indirect immunoﬂuorescence micros-
copy NHEK or HDF were plated on sterile 24  24 mm cover
slips at the density of 1  105 per six-well dish and cultured to
desired points in growth media prior to staining. Cells were fixed
with 3% PFA for 1 h at room temperature (RT) and extensively
washed with cold PBS. The cell membrane was permeabilized at
RT with PBS containing 0.1% Triton and 0.1% Tween (5 min each)
and cells were washed twice in PBS. The cover slips were incu-
bated with primary antibodies overnight at 41C (Table S1), followed
by FITC-conjugated goat anti-mouse or goat anti-rabbit secondary
antibody incubation (Molecular Probes, Eugene, Oregon). DNA
was counterstained with Hoechst (10 mg per mL). Cells were
mounted in Flouprep solution (BioMerieux, Maroy d’Etoile, France)
prior to fluorescence microscopy. Healthy skin specimens ob-
tained from breast and abdominal reduction surgery (n¼ 4) and
skin biopsies obtained for diagnostic purposes from patients suf-
fering from psoriasis (n¼ 8) were fixed in paraformaldehyde and
embedded in paraffin. Sections (5 mm) were heated at 601C over-
night. De-waxed sections were boiled twice in Antigen Retrival
Buffer (Dako, Glostrup, Denmark) in a microwave oven at 500 W for
5 min each and cooled down to RT. Sections were incubated
30 min in PBS with 2% BSA and 10% normal goat serum to block
the non-specific binding of the secondary antibodies. Incubation
with primary and secondary antibodies as well as DNA counter-
staining was performed as described above. Some skin samples
were also stained with antibodies against cytokeratin 5 (K5) and
involucrin (see Table S1). To quantify immunofluorescence, sec-
tions of normal skin (n¼ 3) and psoriasis vulgaris (n¼ 5) were
stained with antibodies against c-Fos and c-Jun. The exposure
time was adjusted to the strongest micrograph and held constant
for all other sections. For each antibody, the intensity of the signal
was quantified in every specimen in 30 nuclei of every epidermal
layer, with the exception of c-Jun staining in the granular layer of
normal epidermis, where 10 nuclei of normal (n¼ 3) and psoriatic
(n¼ 5) samples were counted. The intensity of the signal was
quantified using Metamorph Software and was normalized for the
number of counted nuclei and the intensity of the background
staining in every epidermal layer. Statistical analysis was per-
formed using two-sided t test where po0.05 was accepted as
significant; error bars represent the standard deviation.
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Figure S1
Characterization of monoclonal antibodies and antisera against
AP-1 family members. Cross-reactivity among AP-1 proteins was test-
ed by western blotting with antibodies against Fos (A) or Jun (B). Pos-
itive controls were generated by in-vitro translation of AP-1 proteins,
except for FosB, where extracts from FosB-transfected 293 cells were
used. For negative controls, extracts from mouse ﬁbroblasts deﬁcient in
the corresponding AP-1 proteins were used. Non-specific bands are
indicated by asterisk (). AP-1 induction in response to FCS stimulation
was monitored using immunoﬂuorescence. HDFs were starved for 2
days and either re-stimulated for 3 h with 20% FCS (þ ) or not stim-
ulated (-). Cells were immunostained with antibodies against Fos (C) or
Jun (D) proteins. As controls for immunostaining, corresponding
immunoglobulin isotypes (Table S1) or normal rabbit immunoglubulins
(IgGs) were used. h¼human origin; m¼mouse origin; neo¼ neo-fu-
sions used to generate c-Fos, c-Jun and JunB knockouts. Bars¼50 mm.
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Table S1.
Antibodies used in this study: Description of the antibodies used in
our experiments. The reference, the isotypes, the supplier as well as the
different dilutions used for immunoﬂuorescence staining (IF) and West-
ern Blot analysis (WB) are indicated. Based on our study, the speciﬁcity
for human and/or mouse tissue for the AP-1 antibodies is indicated.
Important remarks are also depicted. m¼mouse; r¼ rabbit; cr¼ cross-
reaction
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